Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 321
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04623021 | A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia | ||
| NCT03346187 | A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 | ||
| NCT04322032 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389 | ||
| NCT05834595 | A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 | ||
| NCT05897216 | Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029 | ||
| NCT03211143 | A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects | ||
| NCT06430047 | Efficacy and Safety of EsoDuo® | ||
| NCT03802162 | A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355 | ||
| NCT04471441 | Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients. | ||
| NCT02064621 | CKD-330 Drug-Drug Interaction Study (Candesartan) | ||
| NCT05587699 | The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A | ||
| NCT02288338 | CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers | ||
| NCT06399068 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions | ||
| NCT05931224 | Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy | ||
| NCT04678388 | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions | ||
| NCT01842269 | Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients | ||
| NCT01106131 | Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin | ||
| NCT05719155 | Pharmacokinetics and Safety/Tolerability of CKD-379 | ||
| NCT02854748 | Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin | ||
| NCT02586311 | CKD-330 Phase 3 Trial in Amlodipine Non-responder | ||
| NCT04488900 | Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects | ||
| NCT04627207 | A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers | ||
| NCT00826644 | Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient | ||
| NCT03437785 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet | ||
| NCT07198191 | SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study | ||
| NCT02589457 | Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet | ||
| NCT04840745 | The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1 | ||
| NCT02753504 | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 | ||
| NCT02044250 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM) | ||
| NCT03616392 | Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308 | ||
| NCT06695572 | Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers | ||
| NCT03849339 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition | ||
| NCT03051841 | CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma | ||
| NCT02648854 | Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers | ||
| NCT06643819 | Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A | ||
| NCT01005160 | Drug Interaction Between CKD-501 and Metformin | ||
| NCT06727396 | A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants | ||
| NCT05544214 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects | ||
| NCT04539652 | Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients | ||
| NCT04673682 | A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845 | ||
| NCT03431623 | CKD-11101 Phase 3 SC Study | ||
| NCT04694989 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) | ||
| NCT04083872 | Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) | ||
| NCT03076957 | A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj. | ||
| NCT02623868 | Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject. | ||
| NCT04221360 | A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375 | ||
| NCT02247518 | CKD-397 Drug-drug Interaction Study (A) | ||
| NCT04255589 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 | ||
| NCT05452525 | Pharmacokinetics and Safety/Tolerability Profile of CKD-379 | ||
| NCT04075643 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers |
